Edesa Biotech, Inc. (EDSA) vs Harvard Bioscience, Inc. (HBIO)
A side-by-side comparison of Edesa Biotech, Inc. and Harvard Bioscience, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
EDSA
Edesa Biotech, Inc.
$3.93HealthcareDelayed quote: Oct 6, 2026, 10:07 AM EDT
HBIO
Harvard Bioscience, Inc.
$8.63HealthcareDelayed quote: Oct 6, 2026, 10:09 AM EDT
Total return — EDSA vs HBIO
growth of $100 · dividends reinvested · last 10yEDSA -99.4% (-40.3%/yr)HBIO -69.0% (-11.0%/yr)HBIO compounded faster over this window
Log scale — wide-divergence pair
EDSA HBIO
EDSA vs HBIO: by the numbers
- •HBIO is the larger company ($39M vs $38M market cap).
- •Both run net losses; EDSA's is the smaller (0.00% vs -11.86% net margin).
Metrics side by side
Valuation
| Metric | EDSA | HBIO |
|---|---|---|
| P/S ratio | N/A | 0.44 |
| P/B ratio | 94.77 | 5.24 |
| EV / EBITDA | N/A | 10.58 |
Profitability
| Metric | EDSA | HBIO |
|---|---|---|
| Gross margin | 0.00% | 58.16% |
| Operating margin | 0.00% | 1.17% |
| Net margin | 0.00% | -11.86% |
| ROE | -160.05% | -140.36% |
| ROIC | -166.02% | 1.99% |
Growth (annualized)
| Metric | EDSA | HBIO |
|---|---|---|
| Revenue CAGR (5Y) | N/A | -4.62% |
| Total return CAGR (5Y) | -39.88% | -34.33% |
Frequently asked
- How have EDSA and HBIO total returns compared?
- Over the past 10 years, EDSA delivered -40.32% and HBIO delivered -11.05% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.